SCHEMBL1573687

SCHEMBL1573687

[O-][S+](c1ccccn1)c1ccccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
LMNA P02545 4/20 0.43
CCR1 P32246 2/20 0.43
CCR5 P51681 2/20 0.43
CCR8 P51685 2/20 0.43
P4HTM Q9NXG6 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
METAP1 P53582 1/20 0.43
BLM P54132 1/20 0.43
HIF1A Q16665 1/20 0.43
DOHH Q9BU89 1/20 0.43
TDP1 Q9NUW8 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
NOS3 P29474 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034185 0.86 KDM4E (0.38) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30837415 0.80
SCHEMBL29181146 0.80
SCHEMBL3254805 0.80
SCHEMBL6970710 0.80
SCHEMBL2759539 0.80
SCHEMBL20048805 0.80
SCHEMBL11539596 0.80 ALDH1A1 (0.34) KDM4ELMNACCR1CCR5CCR8
SCHEMBL5082430 0.78 KDM4E (0.39) KDM4ELMNACCR1CCR5CCR8
SCHEMBL9098260 0.78 PDPK1 (0.36) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049527-A2 PREPARATION OF IRBESARTAN Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2009-04-22 EP claimed
WO-2006073376-A2 PREPARATION OF IRBESARTAN KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) 2006-07-13 WO claimed
JP-3086862-A None JP disclosed
CN-110678458-A Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders 武田药品工业株式会社 2020-01-10 CN disclosed
CN-105541796-A Synthetic method of NH-1,2,3-triazole bipyridine compounds WUHAN INST TECHNOLOGY 2016-05-04 CN disclosed
CN-103709144-A Pyrimidine derivatives substituted picolyl sulfoxide compound and preparation method thereof ANHUI COSTAR BIO CHEMICAL CO LTD 2014-04-09 CN disclosed
CN-103524494-A Sulfydryl imidazole derivative comprising picoline group and synthetic method ANHUI COSTAR BIO CHEMICAL CO LTD 2014-01-22 CN disclosed
CN-103524494-A Sulfydryl imidazole derivative comprising picoline group and synthetic method ANHUI COSTAR BIO CHEMICAL CO LTD 2014-01-22 CN disclosed
EP-1548005-B1 PROCESS FOR PRODUCING 2-SUBSTITUTED PYRIDINE DERIVATIVE KURARAY CO (JP) 2011-04-13 EP disclosed
US-7560563-B2 Process for producing 2-substituted pyridine derivative KURARAY CO., LTD. (JP) 2009-07-14 US disclosed
EP-2049527-A2 PREPARATION OF IRBESARTAN Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2009-04-22 EP disclosed
WO-2002042275-A1 2-ARYL-5-TRIFLUOROMETHYLPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 2002-05-30 WO disclosed
US-6169184-B1 REACTING SUBSTITUTED PYRIDINE WITH SPECIFIED ARYL COMPOUND BASF AKTIENGESELLSCHAFT (DE) 2001-01-02 US disclosed
CN-1230181-A Process for preparing substituted phenylpyridines BASF AG (DE) 1999-09-29 CN disclosed
EP-0931068-A1 PROCESS FOR THE PRODUCTION OF SUBSTITUTED PHENYLPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 1999-07-28 EP disclosed
WO-1998011069-A1 PROCESS FOR THE PRODUCTION OF SUBSTITUTED PHENYLPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 1998-03-19 WO disclosed
EP-0795023-A1 A PROCESS FOR PRODUCING SULPHOXIDE ENRICHED IN THE (R) OR THE (S) ENANTIOMER ZENECA LIMITED (GB) 1997-09-17 EP disclosed
WO-1996017075-A1 A PROCESS FOR PRODUCING SULPHOXIDE ENRICHED IN THE (R) OR THE (S) ENANTIOMER ZENECA LIMITED (GB) 1996-06-06 WO disclosed
JP-H0386862-A NOVEL PROCESS FOR PRODUCING BIPYRIDINE DERIVATIVE WAKO PURE CHEM IND LTD 1991-04-11 JP disclosed
CN-87103523-A The 5-sulfur substituted pyriding monocarboxylic herbicides 1987-12-09 CN disclosed